Market LIVE
Published markets; coverage varies by country
Product profile · United States

CYMBALTA

 ·  Patent Litigation & Settlement History ↓

IngredientDULOXETINE HYDROCHLORIDE
Application typeNDA
Application021427
Product004
Dosage formCAPSULE, DELAYED REL PELLETS
RouteORAL
StrengthEQ 60MG BASE
Approval date2004-08-03
Marketing statusPrescription
Status event—
ApplicantLILLY
Product source

Current GenericRadar decision

Year2013
SelectionEXISTING_GENERIC
ReviewDISQUALIFIED
Anchor typeGENERIC_APPROVAL
Anchor date2013-12-11
Patent anchor—
Exclusivity anchor—
Protection date—
First Final ANDA2013-12-11
Status event—

FDA Final ANDA 090723 explicitly identifies Cymbalta Lilly 20/30/60 mg RLDs. Earliest date is based on candidate source documents and FDA electronic signatures. Evidence limits: see source report.

Patent estate

PatentEffective dateOfficial listingTRUE_DSDS gradeClaim classification / basisPTEPEDFamily
No patent facts are recorded for this product.

Regulatory exclusivity

CodeStart dateEnd dateScopeEntire productAll indicationsFull coverage dateCombinationSource
No exclusivity facts are recorded in this product snapshot.

2026-10-10 · CURRENT_SNAPSHOT_NO_RECORD · Historical coverage: NOT_COMPLETE

2026-10-10 · NO_RECORD_IN_CURRENT_SNAPSHOT · Historical coverage: NOT_COMPLETE

Generic approval evidence

Application / productEventFinal dateTentative dateApplicantAuthorized genericExact mappingSource
090694 / 004FINAL_APPROVAL · FINAL_APPROVED2013-12-11—LUPIN LTDNEXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource
090723 / 003FINAL_APPROVAL · FINAL_APPROVED2013-12-11—ADAPTIS PHARMA PRIVATE LTDNEXACT_PRODUCT · EXACT_PRODUCT_VERIFIEDSource
090723 / 003FINAL_APPROVAL · FINAL_APPROVED2013-12-11—ADAPTIS PHARMA PRIVATE LTDNEXACT_PRODUCT · EXACT_PRODUCT_VERIFIEDSource
090745 / 003FINAL_APPROVAL · FINAL_APPROVED2013-12-11—SUN PHARMACEUTICAL INDUSTRIES LTDNEXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource
090774 / 003FINAL_APPROVAL · FINAL_APPROVED2013-12-11—TORRENT PHARMACEUTICALS LTDNEXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource
090778 / 003FINAL_APPROVAL · FINAL_APPROVED2013-12-11—AUROBINDO PHARMA LTDNEXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource
090783 / 003FINAL_APPROVAL · FINAL_APPROVED2013-12-11—TEVA PHARMACEUTICALS USANEXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource
090723 / 003FINAL_APPROVAL · FINAL_APPROVAL2013-12-11—Dr. Reddy's Laboratories LimitedNEXACT_PRODUCT · EXACT_PRODUCT_VERIFIEDSource
090723 / 003FINAL_APPROVAL · FINAL_APPROVAL2013-12-11—Dr. Reddy's Laboratories LimitedNEXACT_PRODUCT · EXACT_PRODUCT_VERIFIEDSource
090776 / 003FINAL_APPROVAL · FINAL_APPROVED2013-12-17—ACTAVIS ELIZABETH LLCNEXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource
090728 / 003FINAL_APPROVAL · FINAL_APPROVED2014-01-08—ZYDUS PHARMACEUTICALS USA INCNEXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource
090739 / 003FINAL_APPROVAL · FINAL_APPROVED2014-01-08—ZYDUS HEALTHCARE USA LLCNEXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource
202949 / 003FINAL_APPROVAL · FINAL_APPROVED2014-06-09—ALEMBIC PHARMACEUTICALS LTDNEXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource
202045 / 003FINAL_APPROVAL · FINAL_APPROVED2014-06-11—APOTEX INCNEXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource
203088 / 003FINAL_APPROVAL · FINAL_APPROVED2014-06-11—BRECKENRIDGE PHARMACEUTICAL INCNEXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource
203197 / 003FINAL_APPROVAL · FINAL_APPROVED2015-08-26—ALKEM LABORATORIES LTDNEXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource
090780 / 003FINAL_APPROVAL · FINAL_APPROVED2015-10-28—PH HEALTH LTDNEXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource
202336 / 003FINAL_APPROVAL · FINAL_APPROVED2015-10-28—INVENTIA HEALTHCARE LTDNEXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource
204343 / 003FINAL_APPROVAL · FINAL_APPROVED2016-08-03—HETERO LABS LTD UNIT IIINEXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource
208706 / 003FINAL_APPROVAL · FINAL_APPROVED2017-01-06—AJANTA PHARMA LTDNEXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource
204815 / 003FINAL_APPROVAL · FINAL_APPROVED2017-03-23—MACLEODS PHARMACEUTICALS LTDNEXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource
206653 / 003FINAL_APPROVAL · FINAL_APPROVED2017-05-18—PRINSTON PHARMACEUTICAL INCNEXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource
211310 / 003FINAL_APPROVAL · FINAL_APPROVED2018-10-16—CSPC OUYI PHARMACEUTICAL CO LTDNEXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource
210599 / 003FINAL_APPROVAL · FINAL_APPROVED2019-04-17—QINGDAO BAHEAL PHARMACEUTICAL CO LTDNEXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource
207219 / 003FINAL_APPROVAL · FINAL_APPROVED2019-08-16—YAOPHARMA CO LTDNEXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource
212328 / 003FINAL_APPROVAL · FINAL_APPROVED2021-02-11—SUNSHINE LAKE PHARMA CO LTDNEXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource

Market Entry Information

API filings, authorized generics and linked regulatory milestones.

API Master Files & Certifications 0 records

Ingredient-level registrations from linked public manufacturer portfolios. A filing does not establish supply to this finished product. DMFs are not FDA approvals.

APIHolder / manufacturerHolder countryFiling typeNumberStatusFiled dateAvailable for referenceSourceLast verified
No master-file or certification records are linked through public manufacturer portfolios.

Authorized Generics 0 records

Authorized generics are shown separately from independent ANDA approvals.

Application / productApplicantEvent / status First marketed Product mappingSourceLast verified
No authorized-generic records are linked to this product.

Tentative ANDA Approvals 0 records

Tentative approval is not final approval. Historical tentative approvals remain visible after a linked final approval.

Application / productApplicantEvent / status Tentative date Follow-up final approvalProduct mappingSourceLast verified
No tentative-approval records are linked to this product.

Paragraph IV Challenges 0 records

Paragraph IV challenges below are sourced from legal records separately from FDA approvals. An ANDA filing, lawsuit or settlement does not establish final approval or commercial launch.

Application / productApplicantEvent / status Certification event date Product mappingSourceLast verified
No structured Paragraph IV certification events are linked in the available approval evidence.

Final ANDA Approvals 26 records

Approval dates do not establish commercial launch. Product mapping is shown for each linked record.

Application / productApplicantEvent / status Final approval date Product mappingSourceLast verified
090694 / 004LUPIN LTDFINAL_APPROVAL · FINAL_APPROVED2013-12-11 EXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
090723 / 003ADAPTIS PHARMA PRIVATE LTDFINAL_APPROVAL · FINAL_APPROVED2013-12-11 EXACT_PRODUCT · EXACT_PRODUCT_VERIFIEDSource—
090723 / 003ADAPTIS PHARMA PRIVATE LTDFINAL_APPROVAL · FINAL_APPROVED2013-12-11 EXACT_PRODUCT · EXACT_PRODUCT_VERIFIEDSource—
090745 / 003SUN PHARMACEUTICAL INDUSTRIES LTDFINAL_APPROVAL · FINAL_APPROVED2013-12-11 EXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
090774 / 003TORRENT PHARMACEUTICALS LTDFINAL_APPROVAL · FINAL_APPROVED2013-12-11 EXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
090778 / 003AUROBINDO PHARMA LTDFINAL_APPROVAL · FINAL_APPROVED2013-12-11 EXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
090783 / 003TEVA PHARMACEUTICALS USAFINAL_APPROVAL · FINAL_APPROVED2013-12-11 EXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
090723 / 003Dr. Reddy's Laboratories LimitedFINAL_APPROVAL · FINAL_APPROVAL2013-12-11 EXACT_PRODUCT · EXACT_PRODUCT_VERIFIEDSource—
090723 / 003Dr. Reddy's Laboratories LimitedFINAL_APPROVAL · FINAL_APPROVAL2013-12-11 EXACT_PRODUCT · EXACT_PRODUCT_VERIFIEDSource—
090776 / 003ACTAVIS ELIZABETH LLCFINAL_APPROVAL · FINAL_APPROVED2013-12-17 EXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
090728 / 003ZYDUS PHARMACEUTICALS USA INCFINAL_APPROVAL · FINAL_APPROVED2014-01-08 EXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
090739 / 003ZYDUS HEALTHCARE USA LLCFINAL_APPROVAL · FINAL_APPROVED2014-01-08 EXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
202949 / 003ALEMBIC PHARMACEUTICALS LTDFINAL_APPROVAL · FINAL_APPROVED2014-06-09 EXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
202045 / 003APOTEX INCFINAL_APPROVAL · FINAL_APPROVED2014-06-11 EXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
203088 / 003BRECKENRIDGE PHARMACEUTICAL INCFINAL_APPROVAL · FINAL_APPROVED2014-06-11 EXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
203197 / 003ALKEM LABORATORIES LTDFINAL_APPROVAL · FINAL_APPROVED2015-08-26 EXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
090780 / 003PH HEALTH LTDFINAL_APPROVAL · FINAL_APPROVED2015-10-28 EXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
202336 / 003INVENTIA HEALTHCARE LTDFINAL_APPROVAL · FINAL_APPROVED2015-10-28 EXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
204343 / 003HETERO LABS LTD UNIT IIIFINAL_APPROVAL · FINAL_APPROVED2016-08-03 EXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
208706 / 003AJANTA PHARMA LTDFINAL_APPROVAL · FINAL_APPROVED2017-01-06 EXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
204815 / 003MACLEODS PHARMACEUTICALS LTDFINAL_APPROVAL · FINAL_APPROVED2017-03-23 EXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
206653 / 003PRINSTON PHARMACEUTICAL INCFINAL_APPROVAL · FINAL_APPROVED2017-05-18 EXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
211310 / 003CSPC OUYI PHARMACEUTICAL CO LTDFINAL_APPROVAL · FINAL_APPROVED2018-10-16 EXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
210599 / 003QINGDAO BAHEAL PHARMACEUTICAL CO LTDFINAL_APPROVAL · FINAL_APPROVED2019-04-17 EXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
207219 / 003YAOPHARMA CO LTDFINAL_APPROVAL · FINAL_APPROVED2019-08-16 EXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
212328 / 003SUNSHINE LAKE PHARMA CO LTDFINAL_APPROVAL · FINAL_APPROVED2021-02-11 EXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
Decision evidence (1)
TypeDateRoleBasisSource
GENERIC_APPROVAL2013-12-11DISQUALIFYING_FINAL_GENERICFDA Final exact RLD/strength match; tentative not used.Source
Independent legal-event information

Litigation & Settlement History

Settlement launch rights generally apply only to the named parties and product scope. These records do not change GenericRadar patent/exclusivity anchors or current decisions.

No litigation or settlement record currently linked to this product.